Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)

    ... with fludarabine and cladribine before a stem cell transplant in patients with AML or MDS may help to control the ...

    Clinical Trial last updated 04/28/2016 - 3:41pm.

  2. Randomized Allogeneic Azacitidine Study

    ... the disease in patients with AML, CMML, or MDS after an allogeneic (donor) stem cell transplant . The safety of this drug will also be studied. ...

    Clinical Trial last updated 05/03/2016 - 11:08am.

  3. Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... trial studies how well giving donor T cells after donor stem cell transplant works in treating patients with hematologic ... Intervention:  Biological: therapeutic allogeneic lymphocytes Given IV Other Name: ALLOLYMPH Other: laboratory ...

    Clinical Trial last updated 05/03/2016 - 11:17am.

  4. Telomere Length and Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia

    ... Telomere length in hematopoietic stem cell transplantation for severe aplastic anemia: is it ready for "prime time"? ...

    Research Review last updated 05/02/2016 - 9:13am.

  5. Overview of stem cell transplantation for aplastic anemia

    PubMed Abstract:  Allogeneic transplantation for aplastic anemia ... cyclosporine (CsA), or an allogeneic hematopoietic stem cell transplantation (Allo-HSCT).  An Allo-HSCT is a type of bone ...

    Research Review last updated 05/02/2016 - 9:31am.

  6. Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease (UF-BMT-MRD-101)

    ... MDS who have a small amount of detectable disease after allogeneic stem cell transplant . Status:  ...

    Clinical Trial last updated 04/29/2016 - 2:38pm.

  7. Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome

    ... and about 50 percent of responders will relapse. Allogeneic bone marrow transplantation from either HLA -matched sibling ... disorders are not suitable candidates for hematopoietic stem cell transplantation (HSCT) due to advanced age or lack of a histocompatible ...

    Clinical Trial last updated 04/25/2016 - 2:18pm.

  8. Bone Marrow Transplant

    ... There are two basic types of bone marrow /stem cell transplants. A transplant may use cells taken from a donor or from ... patients with bone marrow failure diseases. Allogeneic transplants use cells from a healthy donor. These might come from ...

    Topic section last updated 03/29/2016 - 7:27pm.

  9. Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

    ... disease (GVHD) after nonmyeloablative peripheral blood stem cell (PBSC) transplant in patients with hematological malignancies. Giving ... IV Other Names: Cellcept MMF Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation Undergo nonmyeloablative ...

    Clinical Trial last updated 05/03/2016 - 9:44am.

  10. Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... that of patients undergoing haploidentical RIC hematopoietic stem cell transplantation (HSCT) as reported in the literature and as observed ... Transplantation Undergo PBSC transplant Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Undergo PBSC ...

    Clinical Trial last updated 04/27/2016 - 1:37pm.